Skip to content

Alumis Inc. ALMS Total Assets

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$504.48M+33.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$511.25M-30.9%
Vera Therapeutics logo
Vera TherapeuticsVERA
$621.74M+1.9%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.25B+258%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s total assets?
Alumis Inc. (ALMS) reported total assets of $671.59M in Q1 2026.
How has Alumis Inc.'s total assets changed year-over-year?
Alumis Inc.'s total assets increased by 157.0% year-over-year, from $261.3M to $671.59M.
What is the long-term trend for Alumis Inc.'s total assets?
Over 2 years (2023 to 2025), Alumis Inc.'s total assets has grown at a 114.4% compound annual growth rate (CAGR), from $89.61M to $411.94M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.